These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25598955)

  • 21. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
    Cascinu S; Fedeli A; Del Ferro E; Luzi Fedeli S; Catalano G
    J Clin Oncol; 1994 May; 12(5):1058-62. PubMed ID: 8164030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.
    Bamias A; Aravantinos G; Kalofonos C; Timotheadou N; Siafaka V; Vlahou I; Janinis D; Pectasides D; Pavlidis N; Fountzilas G;
    Oncology; 2003; 64(2):102-10. PubMed ID: 12566906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiac surgery without homologous blood transfusion--the effectiveness and the indication of recombinant human erythropoietin].
    Watanabe Y; Fuse K; Naruse Y; Kobayashi T; Yamamoto S; Konishi H; Horii T
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):499-507. PubMed ID: 8035068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
    Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
    Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.
    Sheffield R; Sullivan SD; Saltiel E; Nishimura L
    Ann Pharmacother; 1997 Jan; 31(1):15-22. PubMed ID: 8997459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E; Madeddu C; Lusso MR; Gramignano G; Mantovani G
    Crit Rev Oncol Hematol; 2006 Feb; 57(2):175-82. PubMed ID: 16213740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
    Baron F; Frère P; Fillet G; Beguin Y
    Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.
    Donato H; Vain N; Rendo P; Vivas N; Prudent L; Larguía M; Digregorio J; Vecchiarelli C; Valverde R; García C; Subotovsky P; Solana C; Gorenstein A
    Pediatrics; 2000 May; 105(5):1066-72. PubMed ID: 10790464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.
    Tatarelli C; Piccioni AL; Maurillo L; Naso V; Battistini R; D'Andrea M; Criscuolo M; Nobile C; Villivà N; Mancini S; Neri B; Breccia M; Fenu S; Buccisano F; Voso MT; Latagliata R; Aloe Spiriti MA
    Ann Hematol; 2014 Aug; 93(8):1413-20. PubMed ID: 24647684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of erythropoietin on allogeneic blood requirement in patients undergoing elective liver resection: a model simulation.
    Lentschener C; Gomola A; Grabar S; Soubrane O; Dousset B; Massault PP; Penhoud C; Ozier Y
    Anesth Analg; 2004 Apr; 98(4):921-926. PubMed ID: 15041573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients.
    Vargas A; Mendoza I; Uranga R; González A; Martínez L; Caballero I; Piedra P; Saurez G; Verdecia M; Cabanas R
    MEDICC Rev; 2010 Jul; 12(3):27-31. PubMed ID: 20697335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules.
    Chaidos A; Makis A; Hatzimichael E; Tsiara S; Gouva M; Tzouvara E; Bourantas KL
    Acta Haematol; 2004; 111(4):189-95. PubMed ID: 15153710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
    Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
    Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
    Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
    Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of chemotherapy-related anaemia with low-dose recombinant human erythropoietin in patients with small cell lung cancer.
    Zarogoulidis K; Papagiannis A; Ziogas E; Fahantidou E; Dermitzakis G; Gioulekas D; Vamvalis C
    Eur J Cancer; 1997 Dec; 33(14):2428-31. PubMed ID: 9616293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
    Durmaz O; Demirkaya M; Sevinir B
    Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.
    Martino M; Oliva E; Console G; Stelitano C; Fujo M; Messina G; Irrera G; Pucci G; Mandaglio R; Callea V; Nobile F; Iacopino P; Morabito F
    Support Care Cancer; 2005 Mar; 13(3):182-7. PubMed ID: 15480819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.
    Vanrenterghem Y; Bárány P; Mann JF; Kerr PG; Wilson J; Baker NF; Gray SJ;
    Kidney Int; 2002 Dec; 62(6):2167-75. PubMed ID: 12427142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.